GSK takes tough measures against resveratrol Sales Manager

GlaxoSmithKline (GSK) has appointed two U.S based executives to stop being associated with non-profit organizations that sell resveratrol supplements Cristoph Westphal and Michelle DIPP, the former Sirtris pharmaceutical industry and now the head of GSK, have all participated in the establishment of the Institute of health and life, a non-profit department that once sold resveratrol dietary supplements for one year A spokesman for GSK told the media that GSK / Sirtris staff had been following the unprofitable Institute of health and life since last year, and reported to the company that what they participated in and their support for the nonprofit had nothing to do with their role in GSK But so far, GSK has not realized that the Institute of health and life sells resveratrol preparations online The company has appointed staff to crack down on this activity, and Michelle DIPP and Christoph Westphal will step down from the foreign director of the Institute of health and life They volunteered to participate in the Institute, and the company confirmed that they were still GSK executives Michelle DIPP and Christoph Westphal all spoke to the public, xconomy quoted DIPP as saying: our main task is to bring new drugs to patients through our work in Longwood and (Glaxo) But resveratrol is too demanding A spokesman for GSK added: 'resveratrol health research is very different from GSK's resveratrol based drugs Resveratrol and srt501 are different preparations Resveratrol is a 250mg / granule powder capsule Srt501 is a 5g liquid suspension Srt501 is the preparation of resveratrol, which has higher bioavailability than the single chemical component Resveratrol, a promise to prolong life, is a strong polyphenol with antifungal chemical properties It is known to contain this active ingredient in grapes and red wine, and has the title of "French paradox" The term was coined by Dr Serge Renaud F of Bordeaux University in 1992, describing France's low incidence of heart disease and obesity despite a relatively high fat diet and high consumption of red wine In 2003, researchers from David Sinclair and partners from Harvard University reported that resveratrol can prolong life, and people are keen to develop this compound The study, published in the journal Nutrition, echoed the international media's praise of the compound and sparked hopes for anti-aging drugs According to Sinclair's research, resveratrol can activate the gene sirtuin 1, which is present in many species, even in the absence of calories, including monkeys Since then, resveratrol has been studied on worms, fruit flies, fish and mice Other resveratrol research reports have anti-cancer, anti-inflammatory, cardiovascular, anti obesity, enhance endurance and fight Alzheimer's disease.